PARTNER 3 at 5 Years: Low-Risk Patients and TAVI… Quo Vadimus?
Five-year results from the PARTNER 3 trial, which evaluated the balloon-expandable SAPIEN 3® TAVI versus surgical aortic valve replacement (SAVR) in low-risk patients.
Five-year results from the PARTNER 3 trial, which evaluated the balloon-expandable SAPIEN 3® TAVI versus surgical aortic valve replacement (SAVR) in low-risk patients.
Update on the status of mitral valve replacement in pediatric patients, by expert Dr. María Luz Polo.
Retrospective, single-center study on the initial 50 cases of aortic root enlargement using Yang’s technique.
A meta-analysis by a Japanese research group compares mid-term survival outcomes for patients with concomitant aortic stenosis and coronary artery disease who underwent either entirely surgical or percutaneous treatment options.
A multicenter registry evaluating the largest series to date regarding the outcomes of transcatheter valve implantation in the mitral position in massive annular calcification (ViMAC) using a transatrial approach during cardiac surgery with cardiopulmonary bypass.
This study examines patients with ischemic heart disease and functional mitral regurgitation (FMR) undergoing coronary artery bypass grafting (CABG) with restrictive mitral annuloplasty (RMA), assessing the effects on left ventricular (LV) volume reduction one year post-surgery.
Comparison of readmission rates and outcomes in patients after biological vs mechanical mitral valve prosthesis implantation in a multicenter American registry.
A multicenter German registry compares short- and mid-term outcomes of transcatheter mitral valve implantation versus surgical reoperation for cases of bioprosthetic degeneration or failed repairs involving annuloplasty.
Review article from Thoracic and Cardiovascular Surgeon that revisits the most relevant articles published in 2022 in the field of cardiac surgery.
International Multicenter SURD-IR Registry Report on Pacemaker Implantation Following Sutureless and Rapid-Deployment Prostheses